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ODONIUM CYCLOPHANES FOR SECURE 
ARENE FUNCTIONALIZATION 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 5 
This application claims priority under 35 U.S.C. S 119(e) to 
U.S. Provisional Application Ser. No. 61/301,491, filed on 
Feb. 4, 2010, which is incorporated by reference in its entirety 
herein. 10 
TECHNICAL FIELD 
This disclosure relates to compounds, reagents, and meth 
ods useful in the synthesis of aryl fluorides, for example, in 15 
the preparation of F labeled radiotracers. The reagents and 
methods provided herein may be used to access abroad range 
of compounds, including aromatic compounds, heteroaro 
matic compounds, amino acids, nucleotides, and synthetic 
compounds. 
2O 
BACKGROUND 
Aryl fluorides are structural moieties in natural products as 
well as a number of therapeutically important compounds, 
including positron emission tomography (PET) tracers and 
pharmaceuticals. Therefore methods and reagents for pro 
ducing such aryl fluorides, for example efficient methods for 
producing aryl fluorides, are desirable. 
25 
SUMMARY 30 
Provided herein are methods of preparing substituted aryl 
and heteroaryl ring systems using iodonium cyclophane com 
pounds, salts, and intermediates. For example, iodonium 
cyclophane salts and iodonium cyclophane fluorides, as pro 
vided herein, can undergo decomposition to prepare an aryl 
fluoride. In the thermal decomposition of unsymmetrial dia 
ryliodonium salts, the identity of the aryl iodide reductively 
eliminated it typically dictated by electronic effects; for 
example, the electron-rich aryl iodide and the functionalized 
electron-poor aromatic compound are formed predominantly 
(see, for example, WO 2010/048170, which is incorporated 
by reference herein). This disclosure provides universal 
“locked aryl substituents that result in StereoElectronic 
Control of Unidirectional Reductive Elimination (SECURE) 
from diaryliodonium salts. Since electronic effects cannot be 
used exclusively to achieve this end, steric and/or stereoelec 
tronic effects can be exploited to gain regiocontrol of reduc 
tive elimination. 
Provided herein are arylligands on iodine that can generate 
a highly strained reductive elimination transition state. This 
strained transition state is created through the introduction of 
significant steric congestion above and/or below the aromatic 
ring in conjunction with little steric congestion in the plane of 
the ring. For example, 2.2paracyclophane iodine(III) salts 
are described herein. 
In some embodiments, the iodonium cyclophane com 
pound can be a compound of Formula (1): 
35 
40 
45 
50 
55 
60 
65 
or Formula (4): 
wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
system; 
X is either a moiety wherein the pKa of the acid H X is less 
than 12 or a leaving group; 
R" is hydrogen or a substituent having a Hammett o, value of 
less than Zero; and 
R,R,R,R,R, and Rare independently selected from the 
group consisting of H. CF. OCF, CN, hydroxyl, amino, 
aminoalkyl, (CH)N(CH2), —SR, SOR, halo, 
SO.R., (CH), OR, C(=O)NR'R', SONRR, 
NRSOR, COOR, NRC(=O)R, NRC(=O)NR, 
SOR, (CH),C(=O)NR'R'', (CH), SONR'R'', (CH), 
NRSO.R., (CH), COOR, (CH), NRC(=O)R’, (CH),NRC(=O)NR, alkoxy, substituted or unsubsti 
tuted alkyl, substituted or unsubstituted alkenyl, substi 
tuted or unsubstituted alkynyl, substituted or unsubstituted 
cycloalkyl, substituted or unsubstituted heterocycloalkyl, 
substituted or unsubstituted aryl, substituted or unsubsti 
tuted heteroaryl, and (L)-Z, or one or more of RandR, 
R" and R', and R and R come together to form a fused 
cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring sys 
tem; 
each m, n, and pare independently an integer from 0 to 10; 
each RandR are independently chosen from H, substituted 
or unsubstituted alkyl, substituted or unsubstituted alkenyl, 
substituted or unsubstituted alkynyl, substituted or unsub 
stituted cycloalkyl, substituted or unsubstituted heterocy 
cloalkyl, substituted or unsubstituted aryl, and substituted 
or unsubstituted heteroaryl; 
L is a linker, and 
Z is a solid Support. 
The X moiety can be one wherein the pKa of the acid H X 
is less than 12. In some embodiments, X is selected from the 
group consisting of halide, aryl carboxylate, alkyl carboxy 
late, phosphate, phosphonate, phosphonite, azide, thiocyan 
ate, cyanate, phenoxide, triflate, trifluoroethoxide, thiolates, 
and stabilized enolates. For example, X can be selected from 
the group consisting of fluoride, chloride, bromide, iodide, 
triflate, trifluoroacetate, benzoate, acetate, phenoxide, trifluo 
roethoxide, cyanate, azide, thiocyanate, thiolates, phos 
phates, and stabilized enolates. In some embodiments, X can 
comprise a radioactive isotope. For example, X can be F or a 
radioactive isotope of F (i.e., 'F). 
In some cases, X is a leaving group. For example, X can be 
selected from the group consisting of triflate, mesylate, non 
aflate, hexaflate, tosylate, nosylate, brosylate, perfluoroalkyl 
sulfonate, tetraphenylborate, hexafluorophosphate, trifluoro 
acetate, tetrafluoroborate, perchlorate, perfluoroalkylcar 
boxylate, chloride, bromide, and iodide. 
The aryl rings on the cyclophane moiety can be substituted 
or unsubstituted. In some embodiments, R' is selected from 
the group consisting of —(C-C)alkyl, —(C-C)ha 
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loalkyl, (C-Co.)alkenyl, (C-C)alkynyl. —O—(C-Co) -continued 
alkyl, —C(O)—O—(C-C)alkyl, aryl, and heteroaryl. For P P2 
example, R' can be -O-(C-Co)alkyl (e.g., OCH). In N1 
some embodiments, R is -O-(C-Co)alkyl (e.g., OCH). 
For example, a compound of Formula (1) can be chosen from: 5 'Nis 
CF O 
RI 
X 
and OP4 
15 N1 
O 
X NP5 
- 2 O 
OP4 
25 2 P P N1 
O 
In some embodiments, one or more of R-R’ is (L)-Z. L 30 O 
and Z can be covalently or noncovalently bound to one 
another. 
The compounds described herein can be used with a variety 
of aryland heteroaryl ring systems. In some embodiments, Ar 35 OP4 
is an electron rich aryl or heteroaryl ring system, for example, PN -P 
Ar—H can be more easily oxidized than benzene. In some N 
embodiments, Ar is chosen from a phenylalanine derivative, O 
tyrosine derivative, typtophan derivative, histidine derivative, NP5 
and estradiol derivative. The Armoiety can be present as a 40 
racemic mixture, enantiomerically pure, or as a mixture O 
thereof. In some embodiments, the Armoiety is enantiomeri 
cally enriched. For example, the Armoiety can be present in 
an enantiomeric excess of at least 75%, an enantiomeric OP3 
O 45 
excess of at least 95%, or an enantiomeric excess of at least P P2 P P2 
O n1 N1 98%. N N 
In some embodiments, Ar can be selected from the group O O 
n N5 consisting of: P5 P 
50 O O 
OP3 
55 OP3 
CN MeO OMe 
P P2 
OMe N1 
60 O 
Me NP5 
O 
OMe 
65 
OMe 
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-continued 
S { Šs 
CN 
/s N 
-N 
le Sox 
CN 
OP3 
P-O 
wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P and P come together to form a single nitrogen 
protecting group: 
each of P, and P' are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 
P is a carboxylic acid protecting group. 
In some embodiments, the compound of Formula (1) is 
chosen from: 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
2 -continued 
P P 
n N 1 
O p51 
p51 
P2 
N 
A 
Pl 
wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P' and P come together to form a single nitrogen 
protecting group: 
each of P, and P' are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 
P is a carboxylic acid protecting group. 
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In some embodiments, the compound of Formula (1) is 
selected from the group consisting of: 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
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In some embodiments, the compound of Formula (1) is 
selected from the group consisting of: 
wherein: 
each of P and P' are independently an alcohol protecting 
group. 
In any of the above embodiments, X can be F. For example, 
X can be 'F. 
In some embodiments, a compound of Formula (1) can be 
a compound of Formula (3): 
wherein Y is a leaving group. For example, Y can be selected 
from the group consisting of triflate, meSylate, nonaflate, 
hexaflate, tosylate, nosylate, brosylate, perfluoroalkyl Sul 
fonate, tetraphenylborate, hexafluorophosphate, trifluoroac 
etate, tetrafluoroborate, perchlorate, perfluoroalkylcarboxy 
late, chloride, bromide, and iodide. 
Further provided herein is a method of making a compound 
of Formula (2): 
Ar—X or 
Formula (5): 
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wherein Aris a substituted or unsubstituted aryl or heteroaryl 
ring system; and X is a moiety whether the pKa of the acid 
H X is less than 12, as described above. The method 
includes heating a solution comprising a compound MX (e.g., 
MF), wherein M is a counter ion and X is as defined above, 
and a compound of Formula (3). 
In some embodiments, the solution comprising MX or MF 
and a compound of Formula (3) can further include a non 
polar solvent. The non-polar solvent can be, for example, 
benzene, toluene, o-Xylene, m-Xylene, p-Xylene, ethylben 
Zene, carbon tetrachloride, hexane, cyclohexane, fluoroben 
Zene, chlorobenzene, nitrobenzene, or mixtures thereof. In 
some embodiments, the solution comprising MX or MF and 
a compound of Formula (3) can further include a polar sol 
vent. The polar solvent can be, for example, acetonitrile, 
acetone, dichloromethane, ethyl acetate, tetrahydrofuran, 
dimethylformamide, 1,2-difluorobenzene, benzotrifluoride, 
or mixtures thereof. 
In some embodiments, the method further comprises fil 
tering the solution to remove insoluble material prior to heat 
ing. In some cases, the solvent is removed from the filtrate 
prior to heating. In some embodiments, the method further 
comprises removing salt by chromatography prior to heating 
(for example, removing salt using gel permeation chromatog 
raphy). 
Heating of the Solution can be done at a temperature rang 
ing from about 25°C. to about 250°C. In some embodiments, 
the heating occurs for from about 1 second to about 25 min 
utes. Heating can be accomplished by any reasonable 
method, for example, by a flash pyrolysis method, a conven 
tional heating method, or by a microwave method. 
Non-limiting examples of a compound of Formula (2) or 
(5) include: 
Šs F 
CN 
r 
N Šs F 
CN 
r 
s Šs F 
CN 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
14 
-continued 
S 
-() 
Šs F 
CN 
S 
& 
Šs F 
CN 
/s N 
N 
1\le 
so F. 
CN 
In some embodiments, the compound of Formula (2) or (5) 
can be chosen from: 
OP3 
P-O1 
F 
OP3 
c. P-O 
wherein: 
each of P and P' are independently an alcohol protecting 
group. 
In some embodiments, the compound of Formula (2) or (5) 
is: 
P P2 N1 
O 
NP5 
18F O 
OP3 
OP4 
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wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P and P come together to form a single nitrogen 
protecting group: 
each of P, and P' are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 
P is a carboxylic acid protecting group. 
For example, the compound can be: 
O O 
t-Bu l ls t-Bu No N o1 
W. O 
s s N 
18F O 
OMe 
OMe 
In some embodiments, the compound of formula (2) or (5) 
is: 
s H OH. 
18F O 
OH 
HO 
Unless otherwise defined, all technical and scientific terms 
used herein have the same meaning as commonly understood 
by one of ordinary skill in the art to which this invention 
belongs. Although methods and materials similar or equiva 
lent to those described herein can be used to practice the 
invention, suitable methods and materials are described 
below. All publications, patent applications, patents, and 
other references mentioned herein are incorporated by refer 
ence in their entirety. In case of conflict, the present specifi 
cation, including definitions, will control. In addition, the 
materials, methods, and examples are illustrative only and not 
intended to be limiting. 
These and other features, aspects and advantages of the 
present teachings will become better understood with refer 
ence to the following description, examples and appended 
claims. 
DESCRIPTION OF DRAWINGS 
FIG. 1 shows the calculated transition state structures and 
activation barriers for a (2,5-dimethylphenyl) and 2.2para 
cyclophan-4-yl iodonium salt. 
DETAILED DESCRIPTION 
Provided herein are methods of preparing substituted aryl 
and heteroaryl ring systems using iodonium cyclophane com 
5 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
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pounds and intermediates. For example, iodonium cyclo 
phane salts and iodonium cyclophane fluorides, as provided 
herein, can undergo decomposition to prepare an aryl fluo 
ride. In the thermal decomposition of unsymmetrial diaryli 
odonium salts, the identity of the aryl iodide reductively 
eliminated it typically dictated by electronic effects; for 
example, the electron-rich aryl iodide and the functionalized 
electron-poor aromatic compound are formed predominantly 
(see, for example, WO 2010/048170, which is incorporated 
by reference herein). This disclosure provides universal 
“locked aryl substituents that result in StereoElectronic 
Control of Unidirectional Reductive Elimination (SECURE) 
from diaryliodonium salts. Since electronic effects cannot be 
used exclusively to achieve this end, steric and/or stereoelec 
tronic effects can be exploited to gain regiocontrol of reduc 
tive elimination. 
DEFINITIONS 
As used herein, the singular forms “a,” “an and “the 
include plural referents unless the context clearly dictates 
otherwise. 
In general, the term “aryl' includes groups having at least 
5 carbon atoms which form a ring structure and have an 
aromatic character, including 5- and 6-membered single-ring 
aromatic groups, such as benzene and phenyl. Furthermore, 
the term “aryl' includes polycyclic aryl groups, e.g., tricyclic, 
bicyclic, Such as naphthalene and anthracene. 
The term "heteroaryl includes groups having at least 5 
atoms which form a ring structure and have an aromatic 
character, including 5- and 6-membered single-ring aromatic 
groups, that have from one to four heteroatoms, for example, 
pyrrole, furan, thiophene, thiazole, isothiaozole, imidazole, 
triazole, tetrazole, pyrazole, oxazole, isooxazole, pyridine, 
pyrazine, pyridazine, and pyrimidine, and the like. Further 
more, the term "heteroaryl' includes polycyclic heteroaryl 
groups, e.g., tricyclic, bicyclic, such as benzoxazole, benzo 
dioxazole, benzothiazole, benzoimidazole, benzothiophene, 
methylenedioxyphenyl, quinoline, isoquinoline, napthridine, 
indole, benzofuran, purine, benzofuran, deaZapurine, inda 
Zole, or indolizine. 
The term “substituted” means that an atom or group of 
atoms formally replaces hydrogen as a “substituent attached 
to another group. For aryl and heteroaryl groups, the term 
“substituted, unless otherwise indicated, refers to any level 
of Substitution, namely mono, di, tri, tetra, or penta Substitu 
tion, where such substitution is permitted. The substituents 
are independently selected, and Substitution may be at any 
chemically accessible position. 
The compounds provided herein may encompass various 
Stereochemical forms and tautomers. The compounds also 
encompasses diastereomers as well as optical isomers, e.g. 
mixtures of enantiomers including racemic mixtures, as well 
as individual enantiomers and diastereomers, which arise as a 
consequence of structural asymmetry in certain compounds. 
Separation of the individual isomers or selective synthesis of 
the individual isomers is accomplished by application of vari 
ous methods which are well known to practitioners in the art. 
As used herein, chemical structures which contain one or 
more stereocenters depicted with bold and dashed bonds, i.e., 
are meant to indicate absolute stereochemistry of the ste 
reocenter(s) present in the chemical structure. As used herein, 
bonds symbolized by a simple line do not indicate a stereo 
preference. Unless otherwise indicated to the contrary, 
chemical structures, which include one or more stereocenters, 
illustrated herein without indicating absolute or relative ste 
reochemistry encompass all possible steroisomeric forms of 
the compound (e.g., diastereomers, enantiomers) and mix 
tures thereof Structures with a single bold or dashed line, and 
US 8,546,578 B2 
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at least one additional simple line, encompass a single enan 
tiomeric series of all possible diastereomers. 
The term “optically enriched' or “enantiomerically 
enriched as used herein refers to the presence of an enantio 
meric excess of either an R or an S isomer at a given stereo 
center of a molecule in a composition. "Enantiomeric excess' 
is defined as F(R)-F(S) for a mixture of (R) and (S) enan 
tiomers, with the composition given as the mole fractions 
F(R) and F(S), where F(R)--F(S)=1. The percent enantio 
meric excess is given by 100IF(R)-F(S)). Enantiomeric 
excess is frequently abbreviated as ee. In some embodiments, 
the ee for each species of a genus is independent of the other 
members of the genus. 
The term “electron rich’, as used herein, refers to an aryl or 
heteroaryl ring system which is more easily oxidized than 
benzene. For example the aryl or heteroaryl ring system may 
be substituted with one or more substituents having a Ham 
mett O, value of less than Zero. 
The term “fluorine', unless explicitly stated otherwise, 
includes all fluorine isotopes. Multiple fluorine isotopes a 
known, however, only 'Fis stable. The radioisotope F has 
a half-life of 109.8 minutes and emits positrons during radio 
active decay. The relative amount of F present at a desig 
nated site in a compound of this disclosure will depend upon 
a number of factors including the isotopic purity of F 
labeled reagents used to make the compound, the efficiency of incorporation of F in the various synthesis steps used to 
prepare the compound, and the length of time since the 'F 
has been produced. When aposition is designated specifically 
as F in the methods and compounds of the present disclo 
sure, the position is understood to have at least about 0.01%. 
at least about 0.1%, at least about 1%, at least about 2%, at 
least about 3%, at least about 4%, at least about 5%, at least 
about 10%, at least about 15%, at least about 20%, at least 
about 25%, at least about 30%, at least about 35%, at least 
about 45%, at least about 50%, at least about 55%, at least 
about 60%, at least about 65%, at least about 70%, at least 
about 75%, at least about 80%, or at least about 85% 'F 
incorporation at that site. 
Compounds 
Provided herein are arylligands on iodine that can generate 
a highly strained reductive elimination transition state. This 
strained transition state is created through the introduction of 
significant steric congestion above and/or below the aromatic 
ring in conjunction with little steric congestion in the plane of 
the ring. On Such ligand is n.ncyclophane. Cyclophanes, as 
described herein, area hydrocarbon consisting of an aromatic 
unit (e.g., a benzene ring) and an aliphatic chain that forms a 
bridge between two non-adjacent positions of the aromatic 
ring. For example, 2.2paracyclophane iodine(III) salts are 
described herein, but those of skill in the art will appreciate 
that other cyclophanes, e.g., 2.2 metacyclophane or 2.2 
orthocyclophane, can also be used in the compounds and 
methods described herein. In addition, cyclophanes are chiral 
and the cyclophane moieties provided herein may be enan 
tiomerically pure, racemic, or a mixture thereof. 
One example of a 2.2paracyclophane iodine(III) salt is a 
compound of Formula 
(1) 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
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wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
system; 
X is either a moiety wherein the pKa of the acid H X is less 
than 12 or a leaving group; 
R" is hydrogen or a substituent having a Hammett o, value of 
less than Zero; and 
R,R,R,R,R, and Rare independently selected from the 
group consisting of H. CF. OCF, CN, hydroxyl, amino, 
aminoalkyl, (CH)N(CH2), —SR, SOR, halo, 
SO.R., (CH), OR, C(=O)NR'R', SONRR, 
NRSOR, COOR, NRC(=O)R, NRC(=O)NR, 
SOR, (CH),C(=O)NR'R'', (CH), SONR'R'', (CH), 
NRSO.R., (CH), COOR, (CH), NRC(=O)R’, (CH),NRC(=O)NR, alkoxy, substituted or unsubsti 
tuted alkyl, substituted or unsubstituted alkenyl, substi 
tuted or unsubstituted alkynyl, substituted or unsubstituted 
cycloalkyl, substituted or unsubstituted heterocycloalkyl, 
substituted or unsubstituted aryl, substituted or unsubsti 
tuted heteroaryl, and (L)-Z, or one or more of RandR, 
R" and R', and R and R come together to form a fused 
cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring sys 
tem; 
each m, n, and pare independently an integer from 0 to 10; 
each RandR are independently chosen from H, substituted 
or unsubstituted alkyl, substituted or unsubstituted alkenyl, 
substituted or unsubstituted alkynyl, substituted or unsub 
stituted cycloalkyl, substituted or unsubstituted heterocy 
cloalkyl, substituted or unsubstituted aryl, and substituted 
or unsubstituted heteroaryl; 
L is a linker, and 
Z is a solid support. 
The X moiety can be selected from atoms and compounds 
in which the pKa of the acid H. X (i.e., the conjugate acid of 
X) is less than about 12. In some cases, X comprises a radio 
active isotope (e.g., 'F, 'I, I, P, and P). In some 
embodiments, X can be chosen from halide, aryl carboxylate, 
alkyl carboxylate, phosphate, phosphonate, phosphonite, 
azide, thiocyanate, cyanate, phenoxide, triflate, trifluoroet 
hoxide, thiolates, and stabilized enolates. For example, X can 
be fluoride, chloride, bromide, iodide, trifluoroacetate, ben 
Zoate, and acetate. In some embodiments, X is fluoride. In 
some embodiments, X is a radioactive isotope of fluoride 
(l 8F) 
X can also be any suitable leaving group. In some embodi 
ments, X is a weakly coordinating anion (i.e., an anion that 
coordinates only weakly with iodine). For example, X can be 
the conjugate base of a strong acid, for example, any anion for 
which the pKa of the conjugate acid (H X) is less than about 
1. For example, X can be triflate, mesylate, nonaflate, 
hexaflate, toluene Sulfonate(tosylate), nitrophenyl Sulfonate (nosylate), bromophenyl sulfonate(brosylate), perfluoroalkyl 
Sulfonate (e.g., perfluoro Co alkyl Sulfonate), tetraphe 
nylborate, hexafluorophosphate, trifluoroacetate, perfluoro 
alkylcarboxylate, tetrafluoroborate, perchlorate, hexafluo 
rostibate, hexachlorostibate, chloride, bromide, or iodide. In 
Some embodiments, a slightly more basic leaving group Such 
as acetate or benzoate may be used. 
The aryl rings that form the cyclophane moeity may be 
substituted or unsubstituted as described above. In some 
embodiments, at least one aryl ring is Substituted with at least 
one substituent having a Hammett O, value of less than Zero (see, for example, “A survey of Hammett substituent con 
stants and resonance and field parameters. Corwin. Hansch, 
A. Leo, R. W. Taft Chem. Rev., 1991, 91 (2), pp 165-195). For 
example, R' can be selected from —(C-Clio)alkyl, (C-Clio) 
alkenyl, (C-Co.)alkynyl, —C(O)—O—(C-Co.)alkyl, aryl, 
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and heteroaryl. In some embodiments, R' can be -O-(C- 
Co.)alkyl, for example, R' can be OCH. Similarly, in some 
embodiments, R can be -O-(C-Co)alkyl, for example, 
R can be OCHs. For example, the compound of Formula (1) 
can be a compound of Formula (1A) or (1B): 
(1A) 
(1B) 
In some embodiments, adjacent R moieties (e.g., R and 
R. RandR', and/or RandR) can come together to form a 
fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring 
system. For example, the cyclophane can include substituted 
or unsubstituted napthyl oranthracyl rings as the upper and/or 
lower aromatic ring moieties. 
In some cases, the cyclophane ligand can be substituted 
with a solid support, Z. A “solid support may be any suitable 
Solid-phase Support which is insoluble in any solvents to be 
used but which can be covalently or noncovalently bound 
(e.g., to the cyclophane ligand or to an optional linker). 
Examples of suitable Solid Supports include polymers such as 
polystyrene (which may be block grafted, for example with 
polyethylene glycol), polyacrylamide, or polypropylene or 
glass or silicon coated with Such a polymer. The solid Support 
may be in the form of small discrete particles such as beads or 
pins, or as a coating on the inner Surface of a reaction vessel, 
for example a cartridge or a microfabricated vessel. See, for 
example, U.S. 2007/0092441. In some embodiments, the 
supports can be sealed into HPLC columns. 
In some embodiments, the Solid Support is covalently or 
noncovalently bound to the cyclophane ligand through the 
use of a linker, L. A "linker can be any suitable organic group 
which serves to space the ligand from the solid Support struc 
ture so as to maximize reactivity. In some embodiments, L 
and Z are covalently bound to one another. For example, a 
linker can include a Co alkyl or a Coalkoxy, attached to 
the Solid Support, for example, a resin can be linked by an 
amide ether or a sulphonamide bond. The linker may also be 
a polyethylene glycol (PEG) linker. Examples of such linkers 
are well known to those skilled in the art of solid-phase 
chemistry. In some cases the linker and solid Support are 
noncovalently bound to one another. Examples of noncova 
lent means for conjugation of a linker and a Solid Support 
include, e.g., ionic bonding, hydrophobic interactions, 
ligand-nucleotide binding, chelating agent/metalion pairs or 
specific binding pairs such as avidin/biotin, Streptavidin/bi 
otin, anti-fluorescein/fluorescein, anti-2,4-dinitrophenol 
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(DNP)/DNP, anti-peroxidase/peroxidase, anti-digoxigenin/ 
digoxigenin or, more generally, receptor/ligand. 
In some embodiments, a fluorous tag (CF) can be 
used as a linker to immobilize a compound of Formula (1) on 
a fluorous Support. For example, Such immobilization can be 
accomplished by using a fluorophobic solvent such as aceto 
nitrile. Examples of fluorous supports include powdered 
polyfluorinated resins (PTFE or PFA (DuPont)) or heavily 
fluorinated silica gels (FluoroFlash (Fluorous Technolo 
gies)). In some embodiments, a linker can comprise a fluorous 
alcohol as the source of the tag. This tag can be linked to the 
cyclophane ligand through any suitable organic linkage, for 
example, an alkyl group, polyethylene glycol (PEG) ethers, 
or mixtures of aliphatic, aromatic, and PEG linkers. In some 
embodiments, the length of the perfluoroalkyl chain on the 
linker can range from CF to CoF. In addition, multiple 
fluorous tags may be incorporated into the same iodonium 
salt. 
The compounds described herein can be used with a variety 
of aryland heteroaryl ring systems. Accordingly, the Armoi 
ety can be any aryl or heteroaryl ring system in which Substi 
tution by X (e.g., F such as 'F) is desired. In some embodi 
ments, the Ar moiety is enantiomerically enriched. For 
example, the Ar moiety can be present in an enantiomeric 
excess of at least 75%, at least 95%, or at least 98%. In some 
embodiments, Ar is enantiomerically pure. 
Ar can be an electron rich aryl or heteroaryl ring system, 
Such as a ring system where Ar—H is more easily oxidized 
than benzene. In some embodiments, Ar is chosen from a 
phenylalanine derivative, tyrosine derivative, typtophan 
derivative, histidine derivative, and estradiol derivative. 
In some embodiments, Ar can be selected from the group 
consisting of: 
CN MeO OMe 
OMe 
Me 
OMe 
OMe 
P P2 N1 
O 
CF O 
OP3 
OP4 
21 
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/s N 
-N 
e 
5 Šs 
10 
S 
Šs 
CN 
—{ 15 
N S 
N P-O 
" wherein: 
CN each of P, P and P' are independently a nitrogen protecting 
Šs 
CN 
Šs 
CN 
OP3 
Šs 
CN 
CN 
group, or P and P come together to form a single nitrogen 
protecting group: 
° each of P. P. and P7 are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 
P is a carboxylic acid protecting group. 
30 Protecting groups as described herein can be a temporary 
substituent which protects a potentially reactive functional 
group from undesired chemical transformations. The choice 
of the particular protecting group employed is well within the 
skill of one of ordinary skill in the art. A number of consid 
erations can determine the choice of protecting group includ 
ing, but not limited to, the functional group being protected, 
other functionality present in the molecule, reaction condi 
tions at each step of the synthetic sequence, other protecting 
groups present in the molecule, functional group tolerance to 
" conditions required to remove the protecting group, and reac 
tion conditions for the thermal decomposition of the com 
pounds provided herein. The field of protecting group chem 
istry has been reviewed (Greene, T. W.; Wuts, P. G. M. 
Protective Groups in Organic Synthesis, 2.sup.nd ed.: Wiley: 
* N.Y., 1991). 
A nitrogen protecting group can be any temporary Substitu 
ent which protects an amine moiety from undesired chemical 
transformations. Examples of Such protecting groups 
so include, but are not limited to allylamine, benzylamines (e.g., 
beZylamine, p-methoxybenzylamine, 2,4-dimethoxybenzy 
lamine, and tritylamine), acetylamide, trichloroacetammide, 
trifluoroacetamide, pent-4-enamide, phthalimides, carbam 
ates (e.g., methyl carbamate, t-butyl carbamate, benzyl car 
ss bamate, allylcarbamates, 2.2.2-trichloroethylcarbamate, and 
9-fluorenylmethyl carbamate), imines, and Sulfonamides 
21 
N 
N 
O | 
(e.g., benzene Sulfonamide, p-toluenesulfonamide, and p-ni 
trobenzenesulfonamide). 
{ An oxygen protecting group can be any temporary Sub 
60 stituent which protects a hydroxyl moiety from undesired 
chemical transformations. Examples of Such protecting 
groups include, but are not limited to esters (e.g., acetyl, 
t-butyl carbonyl, and benzoyl), benzyl (e.g., benzyl, p-meth 
oxybenzyl, and 2,4-dimethoxybenzyl, and trity1), carbonates 
65 (e.g., methyl carbonate, allyl carbonate, 2.2.2-trichloroethyl 
carbonate and benzyl carbonate) ketals, and acetals, and 
ethers. 
21 
N 
N 
35 
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In some embodiments, the compound of Formula (1) can -continued 
be selected from the group consisting of 
2 5 
'N -P 
O p51 
O 10 
P3O 
OP4 15 
P2 Pl N1 wherein: 
each of P' and P are independently a nitrogen protecting 
31' group, or P" and P come together to form a single nitrogen 
protecting group: 
O each of P, and P' are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 
25 P is a carboxylic acid protecting group. 
4 In some cases, the compound of Formula (1) is selected 
OP from the group consisting of 
P2 Pl N 1 N 
30 
O Y P5 Šs 
O O 35 
CN 
OP4 21 
S. 40 N Šs 
P2 Pl n1 N 
O 45 
p51 CN 
21 
O 
N 50 Šs 
P3O 
y 55 CN 
O S 
P2 O V -{ 
N N 
p? 60 Šs 
65 CN 
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-continued wherein Ar, R. R. R. R. R. R. and R7 are as described 
S above. For example, the compound of Formula (4) can be a 
{ compound of Formula (4A) or 4(B): 
N 
5 Šs RI (4A) 
F |-O- Air-I 
CN 10 
/s N (Od N 1\le 
Šs (4B) 
15 
A--(O-R. 
CN 
2O (O) A compound of Formula (1) can also be selected from the 
group consisting of 
P3O 
In some embodiments, F is F. 
25 
The compound of Formula (4) can be selected from the 
group consisting of: 
P2 Pl 
30 N1 
s 
O 
35 
P3O 
OP4 
40 
P2 Pl NN1 
31' 
45 
O 
O p41 
50 
OP4 
P2 Pl 
wherein: NN1 
each of P and P' are independently an alcohol protecting 
group. 55 -O 
Also provided herein is a compound of Formula (4): P 
(4) O 
60 
OP4 
65 
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-continued -continued 
wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P' and P come together to form a single nitrogen 45 
protecting group: 
each of P, and P' are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 50 CN 
P is a carboxylic acid protecting group. 
In some embodiments, the compound of Formula (4) is 
selected from the group consisting of: NS N 55 /s 
le 
Šs 
Šs 60 
CN 
CN 65 
Also provided herein are compounds of Formula (4) 
selected from the group consisting of: 
  
  
OP3 
33 
Br 
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wherein: 
each of P and P' are independently an alcohol protecting 
group. 
The iodonium cyclophane compounds described herein 
can be prepared from commercially available starting mate 
rials using various methods knownto those of ordinary skill in 
the art. The method used for synthesizing the compounds will 
depend on the functionality present on the Armoiety. Poten 
tially reactive functional groups present on the Armoiety can 
be masked using a protecting group prior to the synthesis of 
the iodonium cyclophane compound. The particular method 
employed for preparing the iodonium cyclophane com 
pounds will be readily apparent to a person of ordinary skill in 
the art. 
For compounds that bear sensitive functionality on the 
accepting group (Ar), organometallic reagents that feature 
more covalent (more stable) C-M bonds can be used. For 
example, organometallic compounds including tin, boron, 
and zinc. If there is no functional group incompatibility, more 
basic organometallic reagents (organolithium, Grignard, etc.) 
can be used to prepare the iodonium cyclophane salts. 
In some embodiments, an unsymmetrical iodonium cyclo 
phane salt can be prepared through the reaction of an arylzinc 
halide (e.g., arylzinc chloride). Arylzinc halide salts can be 
prepared by methods known by those of skill in the art. For 
example, 4-Bromo-2.2paracyclophane can be lithiated 
(e.g., using t-BuLi, EtO, -78°C.) and transmetalated with 
anhydrous zinc chloride to prepare an arylzinc chloride. This 
salt can then be reacted with an aryl iodonium salt (e.g., 
2,5-dimethylphenyliodonium diacetate) at low temperature 
(e.g., -40°C.) to prepare a compound of Formula (I). Ion 
exchange or other method can be used to alter the nucleophile 
(e.g., X) as desired. 
For example, a compound of Formula (1) can be made 
using the reaction shown in Scheme 1. 
Scheme 1. 
61% 86% 
(2 steps) 
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-continued 
PF 
O 
5 
56% 
(3 steps) 
a. 1. t-BuLi, Et2O,-78°C., 2. B(OMe)33.H2O2, NaOH, H2O: 
b. K2CO3, CHI, CH3CN, 80°C.; 
c. NBS, CH2Cl2: 
d. 1, t-BuLi, Et2O, -78°C., 2, ZnCl2; and 
e, 1.4-MeOC6H4I(OAc)2, CH3CN, -40°C., f, NaPF6, H2O. 
e, f 
-a- 
Additional examples are provided in the Examples section 
below. 
Persons skilled in the art will be aware of variations of, and 
alternatives to, the processes described which allow the com 
pounds defined herein to be obtained. 
It will also be appreciated by persons skilled in the art that, 
within certain of the processes described, the order of the 
synthetic steps employed may be varied and will depend inter 
alia on factors such as the nature of other functional groups 
present in a particular substrate, the availability of key inter 
mediates, and the protecting group strategy (if any) to be 
adopted. Clearly, such factors will also influence the choice of 
reagent for use in the synthetic steps. 
The skilled person will appreciate that the iodonium cyclo 
phane compounds described could be made by methods other 
than those herein described, by adaptation of the methods 
herein described and/or adaptation of methods known in the 
art, for example US 2007/0092441, or using standard text 
books such as “Comprehensive Organic Transformations—A 
Guide to Functional Group Transformations, RC Larock, 
Wiley-VCH (1999 or later editions) and “Science of Synthe 
sis”, Volume 31a, 2007 (Houben-Weyl. Thieme) 
Methods of Preparing Substituted Aryl and Heteroaryl Ring 
Systems 
Provided herein are methods of preparing substituted aryl 
and heteroaryl ring systems using iodonium cyclophane com 
pounds, salts, and intermediates. For example, iodonium 
cyclophane salts and iodonium cyclophane fluorides, as pro 
vided herein, can undergo decomposition to prepare an aryl 
fluoride. 
For example, provided herein is a method of making a 
compound of Formula (2): 
wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
system; and 
X is a moiety wherein the pKa of the acid H X is less than 
12. In some embodiments, a compound of Formula (2) can 
be prepared as shown in Scheme 2. 
MeO O ZnCl 
25 
Scheme 2. 
Y X 
Ar-i-CP MX - Ar-i-CP - X-Ar 
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wherein CP is a cyclophane ligand as described herein. 
In some embodiments, a compound of Formula (2) can be 
prepared by heating a solution having a compound MX. 
wherein M is a counter ion and X is as defined above, and a 
compound of Formula (3): 
(3) 
wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
system as described above; 
Y is a leaving group; 
R" is hydrogen or a substituent having a Hammett o, value of 
less than Zero; and 
R. R. R. R. R. and R7 are independently selected from the 
group consisting of H. CF. OCF, CN, hydroxyl, amino, 
aminoalkyl, (CH)N(CH2), —SR, SOR, halo, 
SO.R., (CH), OR, C(=O)NR'R'', SONRR, 
NRSOR, COOR, NRC(=O)R, NRC(=O)NR, 
SO.R. (CH),C(=O)NR'R'', (CH), SONRR, (CH), 
NRSO.R., (CH), COOR, (CH), NRC(=O)R’, (CH),NRC(=O)NR, alkoxy, substituted or unsubsti 
tuted alkyl, substituted or unsubstituted alkenyl, substi 
tuted or unsubstituted alkynyl, substituted or unsubstituted 
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cycloalkyl, substituted or unsubstituted heterocycloalkyl, 
substituted or unsubstituted aryl, substituted or unsubsti 
tuted heteroaryl, and (L)-Z, or one or more of R and R. 
R" and R', and Rand R' come together to form a fused 
cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring sys 
tem; 
each m, n, and pare independently an integer from 0 to 10; 
each RandR are independently chosen from H, substituted 
or unsubstituted alkyl, substituted or unsubstituted alkenyl, 
substituted or unsubstituted alkynyl, substituted or unsub 
stituted cycloalkyl, substituted or unsubstituted heterocy 
cloalkyl, substituted or unsubstituted aryl, and substituted 
or unsubstituted heteroaryl; 
L is a linker; and 
Z is a Solid Support. 
Substituted aryls and heteroaryls which are prepared using 
the methods described herein can have an X moiety which 
includes any moiety in which the pKa of H X (i.e., the 
conjugate acid of X) is less than about 12. In some cases, X 
comprises a radioactive isotope (e.g., 'F, ‘I, I, P, and 
P). In some embodiments, X can be chosen from halide, 
aryl carboxylate, alkyl carboxylate, phosphate, phosphonate, 
phosphonite, azide, thiocyanate, cyanate, phenoxide, triflate, 
trifluoroethoxide, thiolates, and stabilized enolates. For 
example, X can be fluoride, chloride, bromide, iodide, trif 
luoroacetate, benzoate, and acetate. In some embodiments, X 
is fluoride. In some embodiments, X is a radioactive isotope 
of fluoride (e.g., 'F). 
Y can be any Suitable leaving group. In some embodi 
ments, Y is a weakly coordinating anion (i.e., an anion that 
coordinates only weakly with iodine). For example, Y can be 
the conjugate base of a strong acid, for example, any anion for 
which the pKa of the conjugate acid (H Y) is less than about 
1. In some embodiments, Y is chosen from triflate, mesylate, 
nonaflate, hexaflate, toluene Sulfonate(tosylate), nitrophenyl 
Sulfonate(nosylate), bromophenyl Sulfonate(brosylate), per 
fluoroalkyl sulfonate (e.g., perfluoro Co alkyl sulfonate), 
tetraphenylborate, hexafluorophosphate, trifluoroacetate, 
perfluoroalkylcarboxylate, tetrafluoroborate, perchlorate, 
hexafluorostibate, hexachlorostibate, chloride, bromide, and 
iodide. In some embodiments, a slightly more basic leaving 
group Such as acetate or benzoate may be used. 
The counterion M can be any suitable cation for the desired 
X. The choice of the source of X, and accordingly M, is 
readily within the knowledge of one of ordinary skill in the 
art. For example, M can be chosen from an alkali metal, 
alkaline earth metal and transition metal salts such as, for 
example, calcium, magnesium, potassium, Sodium and Zinc 
salts. Metal cations may also be complexed to cryptands or 
crown ethers to enhance their solubility and to labilize the X 
moiety. M can also include organic salts made from quater 
nized amines derived from, for example, N.N' dibenzylethyl 
enediamine, chloroprocaine, choline, diethanolamine, ethyl 
enediamine, meglumine (N-methylglucamine) and procaine. 
In some embodiments, M can be a lithium, Sodium, potas 
sium, or cesium with cryptands or crown ethers, a tetrasub 
stituted ammonium cation, or phosphonium cation. When X 
is fluoride, the choice of fluoride source is also readily within 
the knowledge of one of ordinary skill in the art. A variety of 
fluoride sources can be used in the preparation of the fluori 
nated aryl and heteroaryl compounds as provided herein, 
including but not limited to NaF. KF, CSF, tetrabutylammo 
nium fluoride, and tetramethylammonium fluoride. In certain 
instances the choice of fluoride source will depend on the 
functionality present on the compound of Formula (3). 
For the compounds of Formula (2) and (3), Ar. R', R. R. 
R. R. R. and R' can be as described above for the com 
pounds of Formula (1) and (4). For example, a compound of 
Formula (3) can be a compound of Formula (3A) or a com 
pound of Formula (3B) 
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(3A) 
RI 
Y |-G Air-I 
(3B) 
A-I-O-R. 
(O) 
In some embodiments, the compound of Formula (3) is 
chosen from: 
OP3 
wherein each of P and P' are independently an alcohol pro 
tecting group. 
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In some cases, the compound of Formula (3) is: 
P2 Pl 
n N 1 
O p51 
O 
OP4 
wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P' and P come together to form a single nitrogen 
protecting group: 
each of P, and P' are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 
P is a carboxylic acid protecting group. For example, the 
compound of Formula (3) is: 
O O 
t-Bu ls l t-Bu No N o1 
1.O '' 
O 
MeO 
OMe 
The methods described above can be useful in the prepa 
ration of fluorinated aryl and heteroaryl ring systems. In 
particular, the methods can be used to prepare radiolabeled 
fluorinated aryl and heteroaryl ring systems (e.g., PET 
radiotracers). Accordingly, provided herein is a method for 
making a compound of Formula (5): 
wherein Aris a substituted or unsubstituted aryl or heteroaryl 
ring system as described herein. The method can include 
heating a solution comprising a compound MF, wherein M is 
a counter ion, and a compound of Formula (3). In some 
embodiments, F is 'F. 
A compound according to Formula (2) or (5) can be chosen 
from: 
OP3 
P-O 
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OP3 
P-O 
wherein each of P and P' are independently an alcohol pro 
tecting group. 
In some embodiments, a compound of Formula (2) or (5) 
1S 
P P2 N1 
O 
NP5 
F O 
OP3 
OP4 
wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P' and P come together to form a single nitrogen 
protecting group: 
each of P, and P are independently an alcohol protecting 
group, or P and P' come together to form a single oxygen 
protecting group; and 
P is a carboxylic acid protecting group. For example, the 
compound of Formula (2) or (5) can be: 
O O 
t-Bu us ls t-Bu No N o1 
-N 
F O 
OMe 
OMe 
In some embodiments, a compound of Formula (2) or (5) 
1S 
s H OH. 
OH 
HO 
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For example, the compound can be chosen from: 
P P2 N1 
O Nps. 
18F O 
OP3 
OP4 
O O 
t-Bu ul ls t-Bu, and No N o1 
-N 
18F O 
OMe 
OMe 
NH2 
OH. 
18F O 
OH 
HO 
In some embodiments, a compound of Formula (2) or (5) 
can be 
s 
CN 
r 
s Šs F 
CN 
r 
s Šs F 
CN 
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S -continued 
–4. 
Šs F 
S CN 
{ 
N 
CN 
CN 
A nonpolar solvent can be any solvent having a dielectric 
constant of less than about 10. For example, a nonpolar sol 
vent can be chosen from benzene, toluene, o-Xylene, m-Xy 
lene, p-Xylene, ethylbenzene, carbon tetrachloride, hexane, 
cyclohexane, fluorobenzene, chlorobenzene, nitrobenzene, 
and mixtures thereof. In some embodiments, the nonpolar 
Solvent is selected from benzene, toluene, cyclohexane, and 
mixtures thereof In some embodiments the nonpolar solvent 
is a mixture, for example a mixture of cyclohexane and tolu 
CC. 
A polar solvent is a solvent having a dielectric constant 
greater than about 10. In some embodiments, the polar Sol 
vent is a polar aprotic solvent, Such as acetonitrile, acetone, 
dichloromethane, ethyl acetate, tetrahydrofuran, dimethyl 
formamide, 1,2-difluorobenzene, benzotrifluoride, and mix 
tures thereof In some embodiments, the polar aprotic solvent 
is acetonitrile. 
The methods described herein can further include filtering 
the solution to remove insoluble material prior to heating. In 
Some embodiments, the insoluble material is a salt. In some 
cases, the solvent can be removed from the filtrate prior to 
heating. For example, the solvent can be removed and the 
filtrate can be dissolved in another solvent prior to heating. In 
Some cases, the method can also include removing salt by 
chromatography (e.g., gel permeation chromatography). For 
example, if a polar solvent is used, it may be desirable to 
remove unwanted salts by chromatography prior to heating. 
Heating can be accomplished by conventional means (e.g., 
heating bath, oven, heat gun, hot plate, Bunsen burner, heat 
ing mantle, and the like), by the use of a microwave, or by 
flash pyrolysis. Typically, the reaction mixture is heated at a 
temperature ranging from about 25°C. to about 250° C. (e.g., 
between about 80° C. to about 200° C., 100° C. to about 200° 
C., about 120° C. to about 170° C., about 120° C. to about 
160° C., about 120° C. to about 150° C., and about 130° C. to 
about 150° C.). In some embodiments, the reaction mixture is 
heated to about 140° C. 
US 8,546,578 B2 
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Heating can occur for any time necessary to complete the 
reaction. For example, heating can occur for from about 1 
second to about 25 minutes (e.g., from about 1 second to 
about 5 second; from about 1 second to about 10 seconds; 
from about 1 second to about 30 seconds; from about 1 second 
to about 1 minute; from about 1 second to about 2 minutes; 
from about 1 second to about 5 minutes; from about 1 second 
to about 8 minutes; from about 1 second to about 15 minutes; 
from about 1 second to about 20 minutes; from about 10 
second to about 25 minutes; from about 30 seconds to about 
25 minutes; from about 1 minute to about 25 minutes; from 
about 5 minutes to about 25 minutes; from about 10 minutes 
to about 25 minutes; from about 22 minutes to about 25 
minutes; from about 5 to about 30 seconds; from about 30 
seconds to about 2 minutes; from about 2 minutes to about 5 
minutes; from about 5 minutes to about 10 minutes; from 
about 5 minutes to about 15 minutes; from about 3 minutes to 
about 8 minutes; from about 8 minutes to about 16 minutes; 
and from about 12 minutes to about 20 minutes). In some 
embodiments, heating can occur for from about 1 second to 
about 15 minutes. 
In the methods described herein, a pressure tube or other 
reinforced closed system can be used in instances where the 
desired temperature is above the boiling point of the solvent 
utilized. 
The reaction can be conducted in the presence of an inert 
gas Such as nitrogenorargon. In some embodiments, steps are 
taken to remove oxygen and/or water from the reaction sol 
vent and starting materials. This can be accomplished by a 
number of methods including distillation of solvents in the 
presence of agents that react with and/or sequester water and 
under an atmosphere of inert gas, and purging the reaction 
vessel with an inert gas. 
The methods described herein can be used when MX (e.g., 
MF) is reacted in an amount ranging from about 1 picomole to 
about 10 millimoles (e.g., about 1 picomole to about 5 milli 
moles; about 1 picomole to about 1 millimole; about 1 pico 
mole to about 500 micromoles; about 1 picomole to about 100 
micromoles; about 1 picomole to about 50 micromoles; about 
1 picomole to about 5 micromoles; about 1 picomole to about 
1 micromole; about 1 picomole to about 500 nanomoles: 
about 1 picomole to about 100 nanomoles; about 1 picomole 
to about 50 nanomoles; about 1 picomole to about 5 nano 
moles; about 1 picomole to about 1 nanomole; about 100 
picomoles to about 10 millimoles; about 500 picomoles to 
about 10 millimoles; about 1 nanomole to about 10 milli 
moles; about 50 nanomoles to about 10 millimoles; about 100 
nanomoles to about 10 millimoles; about 500 nanomoles to 
about 10 millimoles; about 1 micromole to about 10 milli 
moles; about 50 micromoles to about 10 millimoles; about 
100 micromoles to about 10 millimoles; about 500 micro 
moles to about 10 millimoles and about 1 millimole to about 
10 millimoles). In some embodiments, MX is reacted in the 
sample in an amount of less than about 10 millimoles. In 
many cases, the compound of Formula (3) is used in an excess 
when compared to the amount of MX present in the sample. 
In some embodiments, the reaction mixture having MX fur 
ther contains additional compounds which may be present in 
an excess compared to MX. For example, the additional com 
pounds may be present in more than one million fold excess 
compared to MX. 
EXAMPLES 
General Methods 
Synthesis. 
All materials were obtained from commercial sources and 
used as received unless otherwise noted. Zinc chloride melted 
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under dynamic vacuum before use. Diethyl ether was distilled 
under reduced pressure from Sodium/benzophenone. Tet 
rabutylammonium azide (TBAN), tetrabutylammonium 
thiocyanate (TBASCN), sodium phenoxide (NaOPh), 
sodium thiophenoxide (NaSPh), and sodium trifluoroethox 
ide (NaOCHCF) were dried at room temperature in a drying 
pistol (charged with P0s) under dynamic vacuum for one 
week. Acetonitrile and d-acetonitrile were heated at reflux 
over P-Os, distilled into flame-dried storage tubes, and trans 
ferred to an inert atmosphere glovebox. Benzene and de-ben 
Zene were heated at reflux over CaFI overnight and distilled 
directly into flame-dried storage tubes under dry nitrogen. 
Tetrahydrofuran (THF) was dried over Na/benzophenone and 
distilled into a flame dried storage flask under dry nitrogen. 
All glassware, syringes, and NMR tubes were oven dried 
(140°C.) for more than 24 h before they were transferred into 
the glove box for use. All NMR experiments reported here 
were performed using Bruker spectrometers (400, 500, and 
600MHz) at the University of Nebraska-Lincoln. Yields from 
NMR scale reactions were determined by using the residual 
Solvent peak as an internal standard. Additional product 
analyses were performed by GC-MS. 
General Procedure for Reductive Elimination Reactions. 
In a N. charged glovebox, 0.025 mmolofaniodonium salt 
was dissolved in 0.3 mL of dry d-acetonitrile. The solution 
was combined with 0.3 mL d-acetonitrile solution of 1 equiv. 
of the appropriate salt (TBAN (7.1 mg), TBASPh (8.8 mg), 
NaOPh (2.9 mg) NaOCHCF (3.1 mg)). The mixture was 
transferred into a J-Young NMR tube, sealed, taken out of the 
glovebox and an initial NMR spectrum was taken. The NMR 
tube was wrapped with aluminum foil and put into a 45° C. oil 
bath. (For acetate and thiocyanate, more vigorous conditions 
were required. The solutions containing TBAOAc (15 mg) 
and TBASCN (7.5 mg) were heated in an 80° C. oil bath.) The 
progress of the reaction was monitored by "H NMR until no 
I(III) species was left. Product analysis was performed by 'H 
NMR and GC-MS. 
Calculations. 
All calculations were performed using the Gaussian Suite 
of programs and visualization was performed with Gauss 
View. Ground state geometries were identified after driving 
the C-C-I-H dihedral angle through a full range of motion. 
Structures were optimized and their energies calculated using 
DFT B3LYP/DGDZVP methods. Frequency calculations on 
minimized structures were performed to make the Zero point 
energy and thermal corrections. Transition states were opti 
mized at the same computational level. 
Example 1 
Computational study of 2.2paracyclophan-4-yl 
iodonium salts 
AZide transfer in diaryliodonium salts was investigated 
through a computational study as described above. Ground 
and transition state energies were calculated for a highly 
simplified model of azide substitution, loss of HI from the 
HIN3Ar complexes of p-xylene and 2.2paracyclophane. 
For this study, diaryliodonium azides were used as they are 
known to undergo reductive elimination at or near room tem 
perature (see J. J. Lubinkowski et al., J. Org. Chem. 1978, 43. 
2432; and V. V. Grushin et al., Izv. Akad. Nauk SSSR, Ser: 
Khim. 1984, 2332), and because the small azide nucleophile 
has a relatively modest steric demand. The results of the 
computational study are show in FIG. 1. 
Inspection of FIG. 1 shows that movement from the ground 
state to the transition state geometries for azide Substitution is 
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accompanied by ipso carbon rehybridization and deflection 
of the HI group out of the plane. For the xylyl derivative the 
C4-C1-I angle is 161.9°. However, in the 2.2paracyclophan 
4-yl transition state structure the significant steric demand of 
the second ring in the planarchiral ligand inhibits out of plane 
movement of the iodine atom (C4-C1-I angle is)167.2. This 
structural difference is associated with an energetic penalty; 
the calculated free energy of activation for reductive elimina 
tion of HI from the p-xylene salt is 13.7 kcal/mol, while the 
barrier for the cyclophane derivative is 4.8 kcal/mol higher. 
These results indicate that an increase in steric demand above 
the plane of the aromatic ring destabilizes the reductive elimi 
nation transition state. For the 2.2paracyclophan-4-yl iodo 
nium salt, this effect is sufficiently large to provide stereo 
electronic control of unidirectional reductive elimination 
(SECURE). 
Example 2 
Preparation of (2.2paracyclophan-4-yl)(2',5'-dim 
ethylphenyl)iodonium hexafluorophosphate (1) 
{O> 
(O) 
In a 50 mL Schlenk tube under nitrogen, a stirred solution 
of 4-bromocyclophane (1 mmol. 282 mg) in 10 mL of anhy 
drous diethyl ether was cooled to -78°C. A solution oft-BuLi 
(1.7 M in pentane, 2.3 equiv.) was added dropwise and the 
resulting mixture was stirred at -78° C. for 20 minutes and 
then warmed to 0°C. and allowed to stir for an additional 20 
min. The reaction mixture was cooled again to -78°C. before 
a solution of zinc chloride (200 mg, 1.5 mmol) in ether (10 
mL) was added dropwise by cannula. After the addition, the 
reaction mixture was allowed to warm to room temperature 
over the course of one hour before the solvents were removed 
in vacuo. The remaining Solid was dissolved in anhydrous 
CHCN and the solution was cooled to -40° C. and added 
dropwise to precooled (-40° C.) suspension of bis(acety 
loxy)-(2,5-dimethylphenyl)-N-iodane (350 mg, 1 mmol) in 
10 mL of acetonitrile. The mixture was allowed to warm to 
room temperature over 30 minutes before the solvent was 
removed in vacuo. The resulting solid was washed with hex 
anes and then dissolved in aqueous acetonitrile. Addition of 
an aqueous NaPF solution precipitated the product, which 
was extracted from the aqueous mixture with CHC1. The 
organic layer was evaporated, dissolved in a minimal amount 
of CHCl, precipitated with hexanes, filtered and dried in 
vacuo to yield 1 (105 mg, 18% yield). 
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Example 3 
Preparation of (2,5-dimethylphenyl)(4'-methoxyphe 
nyl)iodonium hexafluorophosphate (2) 
Feaf 
FaNE el 
GE) 
MeO -( ) 
In a N. charged glovebox, 1-(diacetoxyiodo)-4-methoxy 
benzene (352 mg, 1 mmol) was dissolved in 1.5 mL of dry 
acetonitrile. The solution was combined with a solution of 
p-toluenesulfonic acid monohydrate (190 mg, 1 mmol) in 1.5 
mL of dry acetonitrile. p-Xylene (117 mg, 1.1 mmol) was 
added and the mixture was allowed to stand at room tempera 
ture for 2 h. Water (10 mL) was added and the mixture was 
extracted (3x5 mL) with hexanes. The water layer was treated 
with NaPF (502 mg, 3 mmol) and the white precipitate was 
extracted from the aqueous layer with CHC1. Evaporation 
of the organic solvent followed by recrystallization from 
diethyl ether/dichloromethane gave 309 mg (65.2%) of (2.5- 
dimethylphenyl)-(4-methoxyphenyl)iodonium hexafluoro 
phosphate. 
Example 4 
Preparation of (2.2paracyclophan-4-yl)(4'-methox 
yphenyl)iodonium hexafluorophosphate (3) 
In a 50 mL Schlenk tube under nitrogen, a stirred solution 
of bromocyclophane (1 mmol. 282 mg) in 10 mL of anhy 
drous diethyl ether was cooled to -78°C. A solution oft-BuLi 
(1.7 M in pentane, 2.3 equiv.) was added dropwise and the 
resulting mixture was stirred at -78°C. for 20 minutes and 
then warmed to 0°C. and allowed to stir for an additional 20 
min. The reaction mixture was cooled again to -78°C. before 
a solution of zinc chloride (200 mg, 1.5 mmol) in ether (10 
mL) was added dropwise by cannula. After the addition, the 
reaction mixture was allowed to warm to room temperature 
over the course of one hour before the solvents were removed 
in vacuo. The remaining Solid was dissolved in anhydrous 
CHCN and the solution was cooled to -40° C. and added 
dropwise to precooled (-40° C.) suspension of bis(acety 
loxy)-(4-methoxyphenyl)-N-iodane (352 mg, 1 mmol) in 10 
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mL of acetonitrile. The mixture was allowed to warm to room 
temperature over 30 minutes before the solvent was removed 
in vacuo. The resulting Solid was washed with hexanes and 
then dissolved in aqueous acetonitrile. Addition of an aque 
ous NaPF solution precipitated the product, which was 
extracted from the aqueous mixture with CHC1. The 
organic layer was evaporated, dissolved in a minimal amount 
of CHCl, precipitated with hexanes, filtered and dried in 
vacuo (225 mg. 38.4% yield). 
Example 5 
Preparation of (7-methoxy 2.2paracyclophanyl)(4'- 
methoxyphenyl)iodonium hexafluorophosphate (4) 
Fo, IF 
P in 
In a 100 mL Schlenk tube, 4-methoxy-7-bromo2.2para 
cyclophane (1.26 mmol. 400.6 mg) was dissolved in 25 mL of 
distilled ether and cooled to -78°C. To the cooled solution, 
1.7Mt-butyl lithium (3.16 mmol. 1.85 mL) was added drop 
wise and the stirred solution was held at -78°C. for 1 hour. A 
solution of anhydrous zinc chloride (1.51 mmol. 206.1 mg) in 
10 mL of diethyl ether was added dropwise to the cooled 
Solution. The mixture was allowed to warm to room tempera 
ture, and the solvent was removed under reduced pressure. 
The residual Solid (organozinc chloride reagent and lithium 
salts) was taken up in anhydrous acetonitrile and cooled to 
-40°C. before a solution of 4-methoxy (diacetoxyiodo)ben 
Zene (1.89 mmol. 665.5 mg) in acetonitrile (10 mL) was 
added in a dropwise fashion. After 1 hour at -40°C., the 
mixture was warmed to room temperature and the solvent was 
removed under reduced pressure. Deionized water and 
sodium hexafluorophosphate (410 mg) were added, followed 
by 50 mL ofdichloromethane. The mixture was transferred to 
a separatory funnel and the organic phase was separated. The 
Solvent was removed by rotary evaporation and the remaining 
solid was dissolved in 5 mL of dichloromethane and dripped 
into 150 mL hexanes. The precipitate was aged for one hour, 
collected by gravity filtration, and dried in vacuo to yield a 
colorless salt (55.6%, 431.7 mg). 
Example 6 
Reductive Elimination from Iodonium Salts 
To compare the directing effects of the electronically simi 
lar p-xylyl and 2.2paracylcophan-4-yl groups, a series of 
unsymmetrical iodonium salts were prepared by the methods 
described in Examples 2-4 (see Table 1) and arene function 
alization by various nucleophiles (X) was investigated (see 
Scheme 3). The salts underwent reductive elimination using 
the general methods described above. 
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Scheme 3. 
O 
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When compound 1 was treated with TBAN and heated at 
45° C. in CD.CN (0.04M), conversion of the diaryliodonium 
azide was complete within a few hours. The azidoxylene was 
formed exclusively in excellent yield, and no azidocyclo 
phane was observed at the detection limit of H NMR spec 
troscopy. This unidirectional elimination was also observed 
with thiocyanate, phenoxide, thiophenoxide, trifluoroethox 
ide, and acetate (Table 1). The observed selectivity (>99:1) 
corresponds to a difference in the free energies of activation 
(DDG) of at least 2.8 kcal/mol. 
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To provide context for the results obtained for compound 1. 
arene functionalization by various nucleophiles (X) in com 
pound 2 was investigated. The regioselectivity observed dur 
ing the reductive elimination of cyclophanyl-substituted dia 
ryliodonium salts mirrors that of 4-methoxyphenyl 
derivatives (Table 1). The 4-methoxyphenyl moiety is one of 
the most effective, commonly employed directing group in 
diaryliodonium chemistry, perfect regioselectivity for arene 
functionalization, however, is not observed with this directing 
group. For the redox active thiophenoxide and phenoxide 
nucleophiles, some loss of regiocontrol was evident and func 
tionalized anisoles were formed. 
To test the relative directing group abilities of 4-methox 
yphenyl and 2.2paracyclophan-4-yl Substituents, the 
unsymmetrical I(III) derivative of compound 3 were prepared 
from 4-methoxy (diacetoxyiodo)benzene (38% yield) and its 
thermal decomposition chemistry examined. More vigorous 
reaction conditions (80° C. CDCN) were necessary to pro 
mote speedy carbon-heteroatom bond formation with acetate 
and thiocyanate from 3 incomparison to 1 or 2. As can be seen 
from inspection of Table 1, the directing group ability of the 
2.2paracyclophane ligand is comparable or slightly Supe 
rior to that of the 4-methoxyphenyl substituent on I(III). 
TABLE 1. 
Yields of reductive elimination products from I(III) salts 
X 1 2 3 
N 99< O 99< O 86 14 
OAc 85 O 99< O 68 31 
OP 87 O 96 4 51 40 
OCHCF 82 O 8O O 19 39 
SCN 99< O 99< O 81 18 
SPh 98 O 95 5 43 52 
X = N 96% 
X = OAct 51% 
X = OPh 84% 
X = SCN 92% 
X = SPh 82% 
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As shown in Table 1, it appears that for oxygen or Sulphur 
nucleophiles the directing group ability of the cyclophane 
ligand diminishes as nucleophile basicity and the driving 
force for functionalizing the more electron-poor ring 
increase. Such a trend is consistent with Hammond's postu 
late and a concerted, reductive elimination mechanism in 
which less steric Strain is developed at the cyclophane ipso 
carbon atom as the reaction becomes more exergonic. 
Example 7 
Kinetics of Reductive Elimination 
The kinetics of aryl azide formation from N. salts of 1, 2 
and 3 were investigated to probe the relative steric and elec 
tronic contributions to the observed regioselectivity. The salts 
underwent reductive elimination using the general method 
described above. The observed rate constants for xylyl azide 
formation (CDCN, 45° C) were 4.2x10's", 5.5x10's", 
and 3.3x10's", corresponding to free energies of activation 
of 21.7, 22.9, and 24.6 kcal/mol for the reactions of 1, 2 and 
3, respectively. The fact that the rate constant for formation of 
azidoxylene is greater for 1 than 2 indicates that 4-iodo-2.2 
paracyclophane is a better leaving group than 4-iodoanisole. 
Since leaving group ability is correlated with the electron 
density on iodine in the aryl iodide being reductively elimi 
nated, these kinetic data show experimentally that the 2.2 
paracyclophane ligand is a more electron-poor aryl Substitu 
ent than 4-methoxyphenyl and that steric destabilization of 
the transition state is responsible for the enhanced directing 
group ability of the 2.2paracyclophane ligand. 
Example 8 
Reductive Elimination with Regiochemical Control 
The reductive elimination of compound 4 with various 
nucleophiles (X) was studied. The salts underwent reductive 
elimination using the general method described above. This 
compound features an electron donating methoxy Substituent 
para to the I(III) center. 
Scheme 4. 
5 
CDCN 
heat 
(O) 
Not 
Observed 
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As shown in Scheme 4, only anisole Substitution was 
observed after the thermal decomposition of the azide, 
acetate, phenoxide, thiocyanate, and thiophenoxide salts. 
However, a mixture of cyclophane- (30%) and anisole-sub 
stituted (60%) products was obtained from the reductive 
elimination of the 2.2.2-trifluoroethoxide salt of 4. The reason 
for the breakdown in regioselectivity was clear from the prod 
uct analysis, which shows roughly equal amounts of 3- and 
4-(2.2.2-trifluoroethoxy)anisole, as well as roughly equal 
amounts of the two CFCHO-substituted cyclophane regioi 
somers. This lack of selectivity and distribution of regioiso 
mers is consistent with a change in mechanism to one involv 
ing benzyne intermediates. For this basic nucleophile, the 
strategy of raising the transition state energy for reductive 
elimination of the aryl iodide enables the benzyne reaction 
manifold to be competitive. 
Example 9 
Fluorination of (4-methoxyphenyl)-(5-methoxy-4- 
2.2paracyclophanyl)-iodonium hexafluorophos 
phate 
In a Ncharged glovebox, 12.3 mg of (4-methoxyphenyl)- 
4-2.2paracyclophanyliodonium hexafluorophosphate (0.02 
mmol) was dissolved in 0.3 mL of dry acetonitrile, to which 
a solution of 1 mg anhydrous TMAF (1 equivalent) in 0.3 mL 
of dry acetonitrile was added dropwise. The solvent was 
evaporated, and the remainder was dissolved in 0.6 mL of 
d-benzene, passed through a 0.2 mm PTFE syringe filter, and 
transferred into a J-Young NMR tube. The tube was sealed, 
taken out of the box, and heated in a 140°C. oil bath for 15 
minutes. Yields of fluorinated arenes were determined by "H 
and F NMR spectroscopy and confirmed by GC-MS. 
4-fluoroanisole was formed in 52% yield, 3-fluoroanisole in 
24% yield, the rest of the fluoride ended up as unidentified 
inorganic species (singlet at -128.1 ppm and multiplets at 
-130.7 ppm in 'F NMR). 
For this salt, decomposition was also performed at 80°C., 
the reaction took 5 hours to finish and 4-fluoroanisole was 
formed in 66% yield, 3-fluoroanisole in 15% yield. 
A number of embodiments of the invention have been 
described. Nevertheless, it will be understood that various 
modifications may be made without departing from the spirit 
and scope of the invention. Accordingly, other embodiments 
are within the scope of the following claims. 
What is claimed is: 
1. A compound of Formula (1): 
wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
system; 
X is either a moiety wherein the pKa of the acid H X is 
less than 12 or a leaving group; 
R" is hydrogen or a substituent having a Hammett o, value 
of less than Zero; and 
R. R. R. R. R. and Rare independently selected from 
the group consisting of H. CF. OCF, CN, hydroxyl, 
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amino, aminoalkyl, (CH), N(CH2), —SR, SOR, 
halo, S.O.R., (CH), OR, C(=O)NR'R'', SONRR, 
NRSOR, COOR, NRC(=O)R, NRC(=O)NR, 
SOR, (CH),C(=O)NR'R'', (CH), SONRR, (CH), NRSO.R., (CH), COOR, (CH)NRC(=O) 
R. (CH), NRC(=O)NR, alkoxy, substituted or 
unsubstituted alkyl, substituted or unsubstituted alkenyl, 
substituted or unsubstituted alkynyl, substituted or 
unsubstituted cycloalkyl, substituted or unsubstituted 
heterocycloalkyl, substituted or unsubstituted aryl, and 
substituted or unsubstituted heteroaryl; 
each mand n is independently an integer from 0 to 10; and 
each Rand Rare independently chosen from H, substi 
tuted or unsubstituted alkyl, substituted or unsubstituted 
alkenyl, substituted or unsubstituted alkynyl, substituted 
or unsubstituted cycloalkyl, substituted or unsubstituted 
heterocycloalkyl, substituted or unsubstituted aryl, and 
substituted or unsubstituted heteroaryl. 
2. The compound of claim 1, wherein X comprises a radio 
active isotope. 
3. The compound of claim 1, whereinX is selected from the 
group consisting of halide, aryl carboxylate, alkyl carboxy 
late, phosphate, phosphonate, phosphonite, azide, thiocyan 
ate, cyanate, phenoxide, triflate, trifluoroethoxide, thiolates, 
and stabilized enolates. 
4. The compound of claim 1, whereinX is selected from the 
group consisting of fluoride, chloride, bromide, iodide, tri 
flate, trifluoroacetate, benzoate, acetate, phenoxide, trifluo 
roethoxide, cyanate, azide, thiocyanate, thiolates, phos 
phates, and stabilized enolates. 
5. The compound of claim 4, wherein X is fluoride. 
6. The compound of claim 5, wherein X is F. 
7. The compound of claim 1, whereinX is selected from the 
group consisting of triflate, mesylate, nonaflate, hexaflate, 
tosylate, nosylate, broSylate, perfluoroalkyl Sulfonate, tet 
raphenylborate, hexafluorophosphate, trifluoroacetate, tet 
rafluoroborate, perchlorate, perfluoroalkylcarboxylate, chlo 
ride, bromide, and iodide. 
8. The compound of claim 1, wherein R' is selected from 
the group consisting of —(C-C)alkyl, —(C-C)ha 
loalkyl, (C-Co.)alkenyl, (C-C)alkynyl, —O—(C-Co) 
alkyl, -C(O)—O—(C-C)alkyl, aryl, and heteroaryl. 
9. The compound of claim 8, wherein R' is —O-(C-Clio) 
alkyl. 
10. The compound of claim 9, wherein R' is OCHs. 
11. The compound of claim 1, wherein Ar is an electron 
rich aryl or heteroaryl ring system. 
12. The compound of claim 11, wherein Ar—H is more 
easily oxidized than benzene. 
13. The compound of claim 1, wherein Aris chosen from a 
phenylalanine derivative, tyrosine derivative, tryptophan 
derivative, histidine derivative, and estradiol derivative. 
14. The compound of claim 1, wherein the compound of 
Formula (1) is a compound of Formula (1A): 
15. The compound of claim 1, wherein Aris selected from 
the group consisting of 
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wherein: 
each of P, P and P are independently a nitrogen protect 
ing group, or P' and P come together to form a single 
nitrogen protecting group: 
each of P, P, and P7 are independently an alcohol pro 
tecting group, or P and P' come together to form a 
single oxygen protecting group; and 
P is a carboxylic acid protecting group. 
16. The compound of claim 1, wherein the compound of 
Formula (1) is selected from the group consisting of 
P2 Pl N1 
O 
P3O 
OP4 
P2 Pl N1 
O 
OP4 
P2 Pl NN1 
O 
OP4 
P2 Pl N1 
O 
P3O 
P5 
O 
O 
59 
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wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P' and P come together to form a single 
nitrogen protecting group: 
each of P, and P are independently an alcohol protecting 
group, or P and P' come together to form a single 
Oxygen protecting group; and 
P is a carboxylic acid protecting group. 
17. The compound of claim 1, wherein the compound of 
Formula (1) is selected from the group consisting of 
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18. The compound of claim 1, wherein the compound of 
Formula (1) is selected from the group consisting of 
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wherein: 
each of P and P are independently an alcohol protecting 
group. 
19. The compound of claim 1, wherein the Armoiety is 
enantiomerically enriched. 
20. The compound of claim 19, wherein the Armoiety is 
present in an enantiomeric excess of at least 75%. 
21. The compound of claim 19, wherein the Armoiety is 
present in an enantiomeric excess of at least 95%. 
22. The compound of claim 19, wherein the Armoiety is 
present in an enantiomeric excess of at least 98%. 
23. A method of making a compound of Formula (2): 
wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
system; and 
X is a moiety wherein the pKa of the acid H X is less than 
12: 
the method comprising heating a solution comprising a 
compound MX, wherein M is a counterion, and a com 
pound of Formula (3): 
wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
system; 
Y is a leaving group; 
R" is hydrogen or a substituent having a Hammett o, value 
of less than Zero; and 
R. R. R. R. R. and R7 are independently selected from 
the group consisting of H, CF. OCF, CN, hydroxyl, 
amino, aminoalkyl, (S)N(C) SR, SOR, 
halo, SOR, (CH), OR, C(=O)NR'R', SONRR, 
NRSOR, COOR, NRC(=O)R, NRC(=O)NR, 
SOR, (CH),C(=O)NR'R'', (CH), SONRR, (CH), NRSO.R., (CH), COOR, (CH), NRC(=O) 
R. (CH), NRC(=O)NR, alkoxy, substituted or 
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unsubstituted alkyl, substituted or unsubstituted alkenyl, 
substituted or unsubstituted alkynyl, substituted or 
unsubstituted cycloalkyl, substituted or unsubstituted 
heterocycloalkyl, substituted or unsubstituted aryl, and 
substituted or unsubstituted heteroaryl; 
each mand n is independently an integer from 0 to 10; and 
each R and Rare independently chosen from H, substi 
tuted or unsubstituted alkyl, substituted or unsubstituted 
alkenyl, substituted or unsubstituted alkynyl, substituted 
or unsubstituted cycloalkyl, substituted or unsubstituted 
heterocycloalkyl, substituted or unsubstituted aryl, and 
substituted or unsubstituted heteroaryl. 
24. The method of claim 23, wherein M is selected from the 
group consisting of potassium, Sodium; cesium; complexes 
of lithium, Sodium, potassium, or cesium with cryptands or 
crown ethers; tetraSubstituted ammonium cations; and phos 
phonium cations. 
25. The method of claim 23, wherein the solution further 
comprises a non-polar solvent. 
26. The method of claim 25, wherein the nonpolar solvent 
is selected from the group consisting of benzene, toluene, 
o-Xylene, m-Xylene, p-Xylene, ethyl benzene, carbon tetra 
chloride, hexane, cyclohexane, fluorobenzene, chloroben 
Zene, nitrobenzene, and mixtures thereof. 
27. The method of claim 25, wherein the method further 
comprises filtering the solution to remove insoluble material 
prior to heating. 
28. The method of claim 27, wherein the solvent is 
removed from the filtrate prior to heating. 
29. The method of claim 23, wherein the solution further 
comprises a polar solvent. 
30. The method of claim 29, wherein the polar solvent is 
chosen from: acetonitrile, acetone, dichloromethane, ethyl 
acetate, tetrahydrofuran, dimethylformamide, 1,2-difluo 
robenzene, benzotrifluoride and mixtures thereof. 
31. The method of claim 29, wherein the method further 
comprises filtering the solution to remove insoluble material 
prior to heating. 
32. The method of claim 31, wherein the solvent is 
removed from the filtrate prior to heating. 
33. The method of claim 29, wherein the method further 
comprises removing salt by chromatography. 
34. The method of claim 33, wherein the chromatography 
is gel permeation chromatography. 
35. The method of claim 23, wherein the heating comprises 
heating at a temperature ranging from about 25°C. to about 
2500 C. 
36. The method of claim 23, wherein the heating occurs for 
from about 1 second to about 25 minutes. 
37. The method of claim 36, wherein the heating is accom 
plished by a flash pyrolysis method, a conventional heating 
method, or by a microwave method. 
38. The method of claim 23, wherein the compound of 
Formula (2) is chosen from: 
CN 
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39. The method of claim 23, wherein the compound of 
Formula (2) is chosen from: 
OP3 
P-O1 
F 
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-continued 43. A compound of Formula (4): 
OP3 
c 5 F Ar 
P-O 7 
wherein: 10 R 
each of P and P' are independently an alcohol protecting 
group. 
40. The method of claim 23, wherein the compound of 
Formula (2) is: wherein: 1s Ar is a Substituted or unsubstituted aryl or heteroaryl ring 
PN-P system; 
N R" is hydrogen or a substituent having a Hammett o, value 
O of less than Zero; and 
NP5 R,R,R,R,R, and Rare independently selected from 
2O the group consisting of H, CF. OCF, CN, hydroxyl, 
18F O amino, aminoalkyl, (CH)N(CH), , SOR, 
halo, SOR, (CH), OR, C(O)NR'R', SONRR, 
NRSOR, COOR, NRC(=O)R, NRC(=O)NR, 
OP3 SOR, (CH),C(=O)NR'R'', (CH), SONRR, (CH), NRSO.R. (CH), COOR, (CH)NRC(=O) 
OP4 25 R. (CH), NRC(=O)NR, alkoxy, substituted or 
unsubstituted alkyl, substituted or unsubstituted alkenyl, 
wherein: substituted or unsubstituted alkynyl, substituted or 
each of P' and P are independently a nitrogen protecting unsubstituted cycloalkyl, substituted or unsubstituted 
group, or Pl and P’ come together to form a single heterocycloalkyl, substituted or unsubstituted aryl, and 
nitrogen protecting group: 30 substituted or unsubstituted heteroaryl; 
each of P, and P' are independently an alcohol protecting each mand n is independently an integer from 0 to 10; and 
group, or P. and P' come together to form a single each Rand Rare independently chosen from H, substi 
oxygen protecting group: and tuted or unsubstituted alkyl, substituted or unsubstituted 
P is a carboxylic acid protecting group. alkenyl, substituted or unsubstituted alkynyl, substituted 
41. The method of claim 40, wherein the compound of or unsubstituted cycloalkyl, substituted or unsubstituted 
Formula (2) is: heterocycloalkyl, substituted or unsubstituted aryl, and 
substituted or unsubstituted heteroaryl. 
O O 44. A method of making a compound of Formula (5): 
ulls Ar—F t-Bu No N o1 t-Bu. " wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
w On system; 
w the method comprising heating a solution comprising a 
18F O compound MF, wherein M is a counterion, and a com 
45 pound of Formula (3): 
OMe 
OMe 50 
Air-I 
42. The method of claim 23, wherein the compound of 
Formula (2) is: 
55 
NH2 
OH. wherein: 
Ar is a substituted or unsubstituted aryl or heteroaryl ring 
60 system; 
18F O Y is a leaving group; 
R" is hydrogen or a substituent having a Hammett o, value 
of less than Zero; and 
OH R,R,R,R,R, and Rare independently selected from 
65 the group consisting of H, CF. OCF, CN, hydroxyl, 
HO amino, aminoalkyl, (CH2)N(CH2), —SR, SOR, 
halo, SOR, (CH), OR, C(=O)NR'R', SONRR, 
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NRSOR, COOR, NRC(=O)R, NRC(=O)NR, 
SO.R., (CH),C(=O)NR'R'', (CH), SONRR, 
(CH), NRSO.R., (CH), COOR, (CH)NRC(=O) 
R. (CH), NRC(=O)NR', alkoxy, substituted or 
unsubstituted alkyl, substituted or unsubstituted alkenyl, 
substituted or unsubstituted alkynyl, substituted or 
unsubstituted cycloalkyl, substituted or unsubstituted 
heterocycloalkyl, substituted or unsubstituted aryl, and 
substituted or unsubstituted heteroaryl; 
each mand n is independently an integer from 0 to 10; and 
each R and Rare independently chosen from H, substi 
tuted or unsubstituted alkyl, substituted or unsubstituted 
alkenyl, substituted or unsubstituted alkynyl, substituted 
or unsubstituted cycloalkyl, substituted or unsubstituted 
heterocycloalkyl, substituted or unsubstituted aryl, and 
substituted or unsubstituted heteroaryl. 
45. The compound of claim 43, wherein F is 'F. 
46. The compound of claim 43, wherein R' is selected from 
the group consisting of —(C-C)alkyl, —(C-C)halo 
alkyl, (C-C)alkenyl, (C-Co.)alkynyl. —O—(C-Co) 
alkyl, —C(O)—O—(C-Co.)alkyl, aryl, and heteroaryl. 
47. The compound of claim 46, wherein R' is O (C- 
Co)alkyl. 
48. The compound of claim 47, wherein R' is OCHs. 
49. The compound of claim 43, wherein Ar is an electron 
rich aryl or heteroaryl ring system. 
50. The compound of claim 49, wherein Ar—H is more 
easily oxidized than benzene. 
51. The compound of claim 43, wherein Aris chosen from 
a phenylalanine derivative, tyrosine derivative, tryptophan 
derivative, histidine derivative, and estradiol derivative. 
52. The compound of claim 43, wherein the compound of 
Formula (4) is a compound of Formula (4A): 
53. The compound of claim 43, wherein the compound of 
Formula (4) is a compound of Formula (4B): 
54. The compound of claim 43, wherein Aris selected from 
the group consisting of 
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s ) 
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six 
P
wherein: 
each of P, P and P are independently a nitrogen protect 
ing group, or P' and P come together to form a single 
nitrogen protecting group: 
each of P, P, and P7 are independently an alcohol pro 
tecting group, or P and P' come together to form a 
single oxygen protecting group; and 
P is a carboxylic acid protecting group. 
55. The compound of claim 43, wherein the compound of 
Formula (4) is selected from the group consisting of 
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Pš 
N 
O NPl 
OP3 
wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P' and P come together to form a single 
nitrogen protecting group: 
each of P, and P are independently an alcohol protecting 
group, or P and P' come together to form a single 
Oxygen protecting group; and 
P is a carboxylic acid protecting group. 
56. The compound of claim 43, wherein the compound of 
Formula (4) is selected from the group consisting of 
Šs 
CN 
r 
N 
N Šs 
CN 
r 
N 
N Šs 
CN 
  
  
  
US 8,546,578 B2 
75 
-continued 
S 
-{ 
N 
CN 
CN 
CN 
57. The compound of claim 43, wherein the compound of 
Formula (4) is selected from the group consisting of 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
76 
wherein: 
each of P and P are independently an alcohol protecting 
group. 
58. The compound of claim 43, wherein the Armoiety is 
enantiomerically enriched. 
59. The compound of claim 58, wherein the Armoiety is 
present in an enantiomeric excess of at least 75%. 
60. The compound of claim 58, wherein the Armoiety is 
present in an enantiomeric excess of at least 95%. 
61. The compound of claim 58, wherein the Armoiety is 
present in an enantiomeric excess of at least 98%. 
62. The method of claim 44, wherein Mis selected from the 
group consisting of potassium; sodium; cesium; complexes 
of lithium, Sodium, potassium, or cesium with cryptands or 
crown ethers; tetraSubstituted ammonium cations; and phos 
phonium cations. 
63. The method of claim 44, wherein the solution further 
comprises a non-polar solvent. 
64. The method of claim 44, wherein the nonpolar solvent 
is selected from the group consisting of benzene, toluene, 
o-Xylene, m-Xylene, p-Xylene, ethyl benzene, carbon tetra 
chloride, hexane, cyclohexane, fluorobenzene, chloroben 
Zene, nitrobenzene, and mixtures thereof. 
65. The method of claim 44, wherein the method further 
comprises filtering the solution to remove insoluble material 
prior to heating. 
66. The method of claim 44, wherein the solvent is 
removed from the filtrate prior to heating. 
67. The method of claim 44, wherein the solution further 
comprises a polar solvent. 
68. The method of claim 67, wherein the polar solvent is 
chosen from: acetonitrile, acetone, dichloromethane, ethyl 
acetate, tetrahydrofuran, dimethylformamide, 1,2-difluo 
robenzene, benzotrifluoride and mixtures thereof. 
69. The method of claim 67, wherein the method further 
comprises filtering the solution to remove insoluble material 
prior to heating. 
70. The method of claim 69, wherein the solvent is 
removed from the filtrate prior to heating. 
71. The method of claim 67, wherein the method further 
comprises removing salt by chromatography. 
72. The method of claim 71, wherein the chromatography 
is gel permeation chromatography. 
73. The method of claim 44, wherein the heating comprises 
heating at a temperature ranging from about 25°C. to about 
2500 C. 
74. The method of claim 44, wherein the heating occurs for 
from about 1 second to about 25 minutes. 
75. The method of claim 73, wherein the heating is accom 
plished by a flash pyrolysis method, a conventional heating 
method, or by a microwave method. 
76. The method of claim 44, wherein the compound of 
Formula (5) is chosen from: 
CN 
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77. The method of claim 44, wherein the compound of 
Formula (5) is chosen from: 
OP3 
P-O1 
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OP3 
P-O 
wherein: 
each of P and P' are independently an alcohol protecting 
group. 
78. The method of claim 44, wherein the compound of 
Formula (5) is: 
OP4 
wherein: 
each of P' and P are independently a nitrogen protecting 
group, or P' and P' come together to form a single 
nitrogen protecting group: 
each of P, and P' are independently an alcohol protecting 
group, or P and P' come together to form a single 
Oxygen protecting group; and 
P is a carboxylic acid protecting group. 
79. The method of claim 78, wherein the compound of 
Formula (5) is: 
OMe 
OMe 
80. The method of claim 44, wherein the compound of 
Formula (5) is: 
OH. 
OH 
HO 
81. The method of claim 44, wherein F is F. 
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82. The method of claim 44, wherein the compound of 
Formula (3) is a compound of Formula (3A): 
(3A) 5 
10 
15 
83. The method of claim 44, wherein the compound of 
Formula (3) is a compound of Formula (3B): 
(3B) 20 
(O) 25 
30 
80 
